Popular Articles
Stretch Mark Remedies

Global Health Funding Soars, Boosted By Unprecedented Private Giving
Well-heeled donors, private corporations and average citizens sending money to their favorite charities are changing the landscape of global health funding, according to a new study by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
generic viagra online
Growth In German Children
German children are taller than 30 years ago, but the increase in height observed during the last century has become slower. In the current edition of Deutsches Arzteblatt International (Dtsch Arztebl Int 2009; 106(23): 377-82), Bettina Gohlke and Joachim Woelfle of the Department of Pediatrics at the University of Bonn summarize the current state of knowledge of changes in height and of the physical development of young people.
News of the day
In Cleveland, Obama Visits 'Model' Clinic
"President Barack Obama arrived at the Cleveland Clinic without fanfareņ€¦ Thursday afternoon" to visit the medical center he"s called a model of low-cost, high-quality care, the Cleveland Plain Dealer reports. Obama said he wasn"t seeking an endorsement from the hospital, only information. "There has been a lot of discussion in Washington about the very different model that we and the Mayo [Clinic] have, and he wanted to understand it better," Clinic CEO Dr. Delos "Toby" Cosgrove said (Zeltner and Townsend, 7/24).
Diagnostics

FDA Authorizes Emergency Use Of Another Test For 2009 H1N1 Influenza Virus

The U.S. Food and Drug Administration announced it has issued an Emergency Use Authorization (EUA) for a another diagnostic test for the 2009 H1N1 influenza virus, whose spread has caused the virus to be characterized as a pandemic by the World Health Organization. The EUA for the Focus Diagnostics Influenza H1N1 (2009) Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) diagnostic test is the third diagnostic test authorized under an EUA by the FDA since the public health emergency involving the 2009 H1N1 influenza virus was declared on April 26, 2009. The EUA allows Focus Diagnostics to distribute the test to laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. This test is not typically utilized in a doctor"s office-it is a complex laboratory test performed in an environment that has the necessary equipment. These tests are intended for use in the detection of the 2009 H1N1 influenza virus in patients with symptoms of respiratory infection. "This authorization will contribute to the nation"s capacity for accurate testing for the 2009 H1N1 influenza virus," said Daniel G. Schultz, M.D., director of the FDA"s Center for Devices and Radiological Health. The Focus Diagnostics test amplifies the viral genetic material obtained from swabs of the nose or throat, or from nasal discharges. A positive result indicates that the patient is infected with the 2009 H1N1 influenza virus. However, the test does not indicate the stage of infection. A negative result does not preclude influenza virus infection. The EUA authority allows the FDA, based on the evaluation of available data and other things, to authorize the use of unapproved medical products or unapproved uses of approved medical products following a determination and declaration of emergency. The Focus Diagnostics test is an unapproved device whose use is authorized by the EUA. The authorization ends when the declaration of emergency is terminated or when the FDA revokes the authorization. Emergency Use Authorization is part of Project BioShield, which became law in July 2004. Focus Diagnostics is based in Cypress, Calif. For more information: FDA"s Guidance on Emergency Use Authorization of Medical Products.. U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):